Acetylsalicylic acid Recruiting Phase 4 Trials for Coronary Artery Disease / Acute Coronary Syndromes (ACS) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04006288Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
NCT03417388Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
NCT03112707Bioresorbable Polymer-Coated EES in Patients at High Bleeding Risk Undergoing PCI Followed by 1-Month DAPT
NCT03560310Ticagrelor and ASA vs. ASA Only After Isolated Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome
NCT04057300Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes
NCT02494895Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)